Longitudinal SARS-CoV-2 Nucleocapsid Antibody Kinetics, Seroreversion, and Implications for Seroepidemiologic Studies

Longitudinal SARS-CoV-2 Nucleocapsid Antibody Kinetics, Seroreversion, and Implications for Seroepidemiologic Studies

Given widespread use of spike antibody in generating coronavirus disease vaccines, SARS-CoV-2 nucleocapsid antibodies are increasingly used to indicate previous infection in serologic surveys. However, longitudinal kinetics and seroreversion are poorly defined. We found substantial seroreversion of...

Full description

Bibliographic Details
Main Authors: Michael Loesche, Elizabeth W. Karlson, Opeyemi Talabi, Guohai Zhou, Natalie Boutin, Rachel Atchley, Gideon Loevinsohn, Jun Bai Park Chang, Mohammad A. Hasdianda, Adetoun Okenla, Elizabeth Sampson, Haley Schram, Karen Magsipoc, Kirsten Goodman, Lauren Donahue, Maureen MacGowan, Lewis A. Novack, Petr Jarolim, Lindsey R. Baden, Eric J. Nilles
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2022-09-01
Series:Emerging Infectious Diseases
Subjects:
SARS-CoV-2
severe acute respiratory syndrome coronavirus 2
coronaviruses
viruses
COVID-19
coronavirus disease
Online Access:https://wwwnc.cdc.gov/eid/article/28/9/22-0729_article

Internet

https://wwwnc.cdc.gov/eid/article/28/9/22-0729_article

Similar Items